Prognostic factors in mucoepidermoid carcinoma of the salivary glands

Catherine H. McHugh, Dianna B. Roberts, Adel K. El-Naggar, Ehab Y. Hanna, Adam S. Garden, Merrill S. Kies, Randal S. Weber, Michael E. Kupferman

Research output: Contribution to journalReview articlepeer-review

150 Scopus citations

Abstract

BACKGROUND: Mucoepidermoid carcinoma (MEC) is the most common malignancy of the major salivary glands. Prior reports noted histological grade and tumor stage as consistently important prognostic factors. This study reviewed the experience of patients with MEC at the University of Texas MD Anderson Cancer Center to determine the impact of clinical and pathologic findings on disease outcomes. METHODS: A retrospective clinical review was performed of patients with salivary gland MEC treated at a tertiary cancer center from 1990 to 2007. RESULTS: A total of 125 patients were included. The 5-year overall survival and disease-free survival of all patients were 79.3% and 76.5%, respectively. Patients with low- and intermediate-grade disease had significantly better overall survival and disease-free survival than patients with high-grade disease, but no difference in survival rates was found between low- and intermediate-grade disease. Pathologic results of positive lymph nodes, extracapsular lymph node spread, and perineural invasion were all found to be poor prognostic indicators. On multivariate analysis, advanced disease stage and perineural invasion were found to be the most significant prognostic factors. CONCLUSIONS: Patients with either low- or intermediate-grade tumors uniformly have favorable local control and survival. High histological grade, advanced stage, perineural invasion, positive surgical margins, and submandibular location all portend for poor outcomes in MEC. Further advances in therapy are needed to improve outcomes for high-grade and advanced-stage disease. Cancer 2012. © 2011 American Cancer Society. High histological grade, advanced stage, perineural invasion, positive surgical margins, and submandibular location all portend poor outcomes of mucoepidermoid carcinoma. Further advances in therapy are needed to improve outcomes for patients with high-grade histology and advanced-stage disease.

Original languageEnglish (US)
Pages (from-to)3928-3936
Number of pages9
JournalCancer
Volume118
Issue number16
DOIs
StatePublished - Aug 15 2012

Keywords

  • mucoepidermoid carcinoma
  • parotid gland
  • salivary gland carcinoma
  • submandibular gland
  • treatment intensification

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Prognostic factors in mucoepidermoid carcinoma of the salivary glands'. Together they form a unique fingerprint.

Cite this